DaBomb Protein Biotech Corp. (TPEX:6578)

DaBomb Protein Biotech Revenue

DaBomb Protein Biotech had revenue of 82.09M TWD in the quarter ending March 31, 2026, with 19.67% growth. This brings the company's revenue in the last twelve months to 322.83M, up 5.76% year-over-year. In the year 2025, DaBomb Protein Biotech had annual revenue of 309.34M, down -8.43%.

• Revenue (ttm): 322.83M
• Revenue Growth: +5.76%
• P/S Ratio: 3.57
• Revenue / Employee: n/a
• Employees: 54
• Market Cap: 1.15B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	309.34M	-28.49M	-8.43%
Dec 31, 2024	337.82M	-46.59M	-12.12%
Dec 31, 2023	384.41M	-49.22M	-11.35%
Dec 31, 2022	433.63M	-37.00M	-7.86%
Dec 31, 2021	470.63M	-134.59M	-22.24%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 20, 2026

Data Sources Report a data error